GHK-Cu Regulatory Status GHK-Cu is not an FDA-approved drug
Mild redness or irritation may occur initially
IV doses of 25-400 mcg/kg for safety studies Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, pharmacokinetics, receptor expression, peptide degradation rates, and tissue distribution patterns
On sale now, but they sell out fast
Consultation with healthcare professionals remains essential for accurate diagnosis, appropriate treatment selection, and ongoing monitoring
Het is geen geneesmiddel, voedingssupplement of cosmetisch product en is niet goedgekeurd voor menselijke consumptie